Error: Could not add to watchlist. X
+ Watchlist

Trius Therapeutics LLC

TSRX:US
Acquired
TSRX:US was acquired by MRK:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.61
Market Cap (USD)
-
Shares Outstanding (m)
48.269
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Trius Therapeutics LLC operates as a biopharmaceutical company. The Company develops antibiotics for life threatening infections. Trius Therapeutics serves clients in the United States.
Address
6310 Nancy Ridge Drive
Suite 105
San Diego, CA 92121
United States
Phone
1-858-452-0370
Website
-
Show More